Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,293 recalls, newest first

Class III · Low risk

Invokamet (canagliflozin and metformin HCl)

Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.

Terminated Labeling / mix-up Janssen Ortho L.L.C. NDC 50458-543-60 D-0115-2017
Class III · Low risk

Zeasorb AF

Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating "use for the cure of most jock itch" rather than "use for the cure of most athlete's foot".

Terminated Labeling / mix-up GSK Consumer Healthcare NDC 0145-1506-01 D-0142-2017
Class III · Low risk

Xanax (Alprazolam)

Labeling: Missing Label-Primary packaging label (i.e. blister card) is blank and contains no product information (e.g. product name, strength, lot number, expiry).

Terminated Labeling / mix-up Mckesson Packaging Services NDC 63739-669-10 D-1527-2016
Class III · Low risk

Lansoprazole Delayed-Release Capsules

Labeling: Label mix-up. The inner packaging was properly labeled Omeprazole DR 40mg Capsules, but the outer secondary packaging was mislabeled Lansoprazole Delayed-Release 30mg Capsules.

Terminated Labeling / mix-up Mckesson Packaging Services NDC 63739-0555-10 D-1550-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-887-32 D-1490-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-909-32 D-1489-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-832-25 D-1488-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-898-32 D-1487-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-815-25 D-1486-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 60687-154-25 D-1485-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-943-25 D-1484-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 60687-133-25 D-1483-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-936-25 D-1482-2016
Class II · Moderate risk

Dextroamphetamine Saccharate

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

Terminated Labeling / mix-up Amerisource Health Services NDC 68084-874-25 D-1481-2016
Class III · Low risk

Lamotrigine Tablets

Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.

Terminated Labeling / mix-up Unichem Pharmaceuticals Usa Inc NDC 29300-113-05 D-1519-2016
Class III · Low risk

Amoxicillin For Oral Suspension

Labeling: Label Error on Declared Strength- bottles missing colored coded panel where strength of the product is displayed.

Terminated Labeling / mix-up West-Ward Pharmaceuticals Corp. NDC 00143-9887-01 D-1515-2016
Class III · Low risk

Mucinex Sinus-Max Day Night

Labeling: Label Error on Declared Strength; label on outer carton incorrectly states Diphenhydramine 25 mg instead of 12.5 mg. Also, quantity is incorrectly stated as 30 daytime and 30 nighttime instead of 36 daytime and 24 nighttime.

Terminated Labeling / mix-up Reckitt Benckiser LLC NDC 63824-207-60 D-1517-2016
Class III · Low risk

Methylprednisolone Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date: incorrect expiration date of 02/0218 is printed on the container label instead of the correct expiration date of 02/2018.

Terminated Labeling / mix-up Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-003-14 D-0205-2017

Recalls by year